Sun Pharmaceutical Industries Ltd. closed 10.33% short of its 52-week high of 1,960.20 rupees, which the company reached on ...

Sun Pharmaceutical Industries Ltd. closed 9.91% short of its 52-week high of 1,960.20 rupees, which the company reached on ...

MUMBAI, India and WALTHAM, Mass., March 9, 2025 /PRNewswire/ -- Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE ...

Sun Pharma will pay an upfront cash consideration of $4.1 per share, representing a 66 percent premium to Checkpoint’s last closing price. Additionally, Checkpoint shareholders will receive a ...

India's Sun Pharmaceutical Industries said on Monday it will acquire Checkpoint Therapeutics , a U.S.-based immunotherapy and targeted oncology company, for $355 million.

Sun Pharma will make an upfront cash payment of $4.10 per share, or a consideration of up to $355 million, the companies said in a joint statement. And the transaction is expected to be completed ...

Analysts expect Sun to continue to be more aggressive in chasing speciality assets, but a successful launch is necessary for the stock to gain brownie points. Sun Pharmaceutical Industries Ltd’s ...

Sun Pharma has agreed to purchase the Massachusetts biotech for an upfront value of $355 million, or $4.10 per share, the companies said Sunday. With Unloxcyt, an FDA-approved PD-L1 therapy for ...

Sun Pharma shares rose like the ... From Delhi To Chennai The Mumbai-based pharma company will make an upfront cash payment of USD 4.1 per share. In addition to that, upon reaching a milestone ...

Investing.com-- Sun Pharmaceutical (TADAWUL ... Sun said it will offer $4.10 in cash for each share in Checkpoint, a nearly 66% premium to Checkpoint’s Friday close of $2.470.